You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 131 No. 8, August 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Challenges in Otolaryngology
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Neuro-otology
 •Hearing Loss/ Deafness
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Intratympanic Steroid Perfusion for Sudden Sensorineural Hearing Loss

Arch Otolaryngol Head Neck Surg. 2005;131:730-732.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Hypothesis: While the traditional treatment for idiopathic, sudden, sensorineural hearing loss (SNHL) is oral steroid therapy (and some argue that no other treatment is needed), intratympanic (IT) steroid therapy also has a role in treating this condition.

A MEDLINE literature search was performed for the years 1980 to 2004. The search strategy included the terms idiopathic hearing loss, sudden hearing loss, sudden sensorineural hearing loss, and steroids. Appropriate articles were selected and reviewed. Only articles published in English were included. Those articles addressing primarily idiopathic sudden SNHL and oral or IT steroid therapy as the preferred means of treatment were included in this analysis.


 
Figure appears in full text version.
Sam J. Marzo, MD


BACKGROUND

Sudden SNHL is relatively common, affecting 5 to 20 individuals per 100 000. It is defined as a sudden hearing loss in 3 contiguous frequencies greater than 30 dB occurring within a 3-day period.1-2 While some drugs (eg, aminogycosides . . . [Full Text of this Article]

PRO

CON

BOTTOM LINE

AUTHOR INFORMATION

Sam J. Marzo, MD
Author Affiliations: Department of Otolaryngology–Head and Neck Surgery, Loyola University Health System, Maywood, Ill.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Diagnostic and Management Dilemma of Sudden Hearing Loss
Aristides Sismanis
Arch Otolaryngol Head Neck Surg. 2005;131(8):733-734.
EXTRACT | FULL TEXT  

Broadening the Spectrum of Treatment Options for SNHL
Hinrich Staecker
Arch Otolaryngol Head Neck Surg. 2005;131(8):734.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.